B A S E C A R E
Good News | Basecare Medical Awarded 2021 Enterprise of the Year in Genetic Testing Industry
September 14, 2021 · Suzhou
Basecare Medical Awarded 2021 Enterprise of the Year in Genetic Testing Industry

Pazhou Pavilion saw the opening of the 2021 Gene Testing Industry Development Summit Forum on September 10. As one of the important branch sites of Guangzhou International Bio-technology Conference & Expo, this forum invited authoritative experts, scholars and business representatives in the field of gene sequencing to come together for the anticipation of industry development prospect and future trend and the solution of genetic testing technology challenges.

In the forum, some honors were set up for appraisal and award, including Enterprise of the Year in Genetic Testing Industry, Man of the Year in Genetic Testing Industry, Anti-epidemic Hero Enterprise in Gene Testing Industry and Most Valuable Investment Enterprise of the Year in Genetic Testing Industry. Basecare Medical won the first one discussed above.

The awards ceremony


The trophy
Regarded as one of the most promising industries in the field of bioscience, gene testing has been applied to medical practices in a continuously extensive scale with widespread use in subdivisions of the life sciences. Committed to the development and clinical application of high-throughput sequencing technology in the field of reproductive health, Basecare Medical, the leading enterprise of assisted reproductive gene testing companies, has created PGT field and its market segment in China as the only innovative medical device company in China that obtained NMPA approval in the field of assisted reproductive gene testing.
In active response to the Healthy China 2030 Development Program, Basecare Medical will continue to shoulder the mission of “helping more families have healthy babies” with persistent efforts in assisted reproduction gene testing to make contributions to “Healthy China” and stride forward the goal of developing as an international brand.